Matthew Plavan
Overview
Matthew Plavan received an average of $800K in total compensation, including $298K in salary, at Arcadia Biosciences from 2016 to 2021. Matthew Plavan also received an average of $554K at Cesca Therapeutics from 2007 to 2015.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
Arcadia BiosciencesFormer President and Chief Executive Officer
Arcadia BiosciencesPresident and Chief Executive Officer
Arcadia BiosciencesPresident and Chief Executive Officer
Arcadia BiosciencesPresident, Arcadia Specialty Genomics and Chief Financial Officer
Arcadia BiosciencesChief Financial Officer
Arcadia BiosciencesChief Financial Officer
Cesca TherapeuticsCEO thru October 28,
Cesca TherapeuticsCEO thru October 28,
Cesca TherapeuticsChief Executive Officer thru
Cesca TherapeuticsChief Executive Officer thru
Source: SEC filings on April 19, 2022, April 20, 2021, April 17, 2020, April 18, 2019, May 17, 2018, January 14, 2016, May 11, 2015, April 4, 2014, October 23, 2012, October 25, 2011, October 26, 2010, and October 26, 2007.
Related executives
We found 37 more executives who work or worked at Arcadia Biosciences and Cesca Therapeutics.
Chris Xu
Cesca Therapeutics
Chief Executive Officer
Haihong Zhu
Cesca Therapeutics
Chief Operating Officer
Jeffery Cauble
Cesca Therapeutics
Chief Financial Officer
Chris Cuvelier
Arcadia Biosciences
Chief Growth Officer
Pamela Haley
Arcadia Biosciences
Chief Financial Officer
Laura Pitlik
Arcadia Biosciences
Chief Marketing Officer
Sarah Reiter
Arcadia Biosciences
Former Chief Commercial Officer
Randall Shultz
Arcadia Biosciences
Chief Technology Officer
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019